We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Mitragynine ELISA Detects Designer Drug

By LabMedica International staff writers
Posted on 17 Apr 2013
A designer drug originates from Mitragyna speciosa, an uncontrolled plant found in South East Asia. More...


Called Kratom, the drug has become more popular because it is easily available on the internet and in head shops [shops specializing in paraphernalia used with or related to illegal drugs]. It is marketed as a means to combat fatigue, pain, and depression. A new immunoassay for Kratom was developed by Randox Toxicology (Crumlin, United Kingdom) and provides a rapid solution for the detection of Mitragynine and its metabolites.

From exotic plants to synthetic blends, designer drugs are problematic for forensic toxicologists as waves of new compounds with differing chemical properties quickly flood the market. Immunoassays provide a straightforward method for laboratory drug screening, allowing a large number of specimens to be screened relatively quickly. A novel ELISA developed by Randox Toxicology can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing valuable information for further analysis.

The Randox Toxicology enzyme-linked immunosorbent assay (ELISA) can detect Mitragynine and its metabolites; 9-O-Desmethylmitragynine, 7-alpha-Hydroxymitragynine, and 7-alpha-Acetoxymitragynin in urine and blood specimens, providing important information for further analysis.

As with other designer drugs such as “Spice” and “Bath Salts,” Kratom is marketed as a “legal high,” which can mislead users to believe that the drug is safe to use. Several cases of psychosis resulting from the use of Kratom have been reported, with individuals addicted to the drug exhibiting psychotic symptoms such as hallucinations, delusion, and confusion. Mitragynine and several related alkaloids naturally occur in the Mitragyna speciosa plant, creating psychoactive properties.

Randox Toxicology, through its research and development capabilities, is able to quickly develop reliable assays for designer drugs. The company has developed a range of rapid immunoassays on ELISA and Biochip arrays, including Synthetic Cannabinoids and Synthetic Cathinones, commonly referred to as “Bath Salts.”

Related Links:
Randox Toxicology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Manual Pipetting Aid
Pipette Controllers macro
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.